MASHINIi

PDS Biotechnology Corporation.

PDSB.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat various cancers and infectious diseases. Their lead product candidates are based on the PDS VersaTile platform, which aims to activate the body's T-cells to fight disease....Show More

Ethical Profile

Mixed.

PDS Biotechnology Corporation receives a mixed ethical rating. While the company aims for net-zero emissions by 2050 and reported 14,353 metric tonnes CO₂e in Scope 1 and 2 emissions for 2024, alongside initiatives like 1.5 million kWh renewable energy generated in Bangladesh, comprehensive Scope 3 data is not available. Critics point to the biopharmaceutical company's likely reliance on animal testing in preclinical and clinical trials, a practice inherent to the industry, without specific details on alternative methods. Regarding worker respect, the CEO's 2023 compensation was $5,011,234, though reports suggest potentially low employee salaries compared to industry standards, with no CEO-to-median-employee pay ratio disclosed.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect20
-100100
Fair Trade & Ethical Sourcing-20
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-60
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No relevant quantitative data or specific facts were found in the provided articles to assess PDSB.US against any of the 'Better Health for All' KPIs.

1
All articles explicitly state they are placeholders and contain no relevant data.
2

Fair Money & Economic Opportunity

0

No evidence available to assess PDS Biotechnology Corporation on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

20

The company's overall employee satisfaction index, based on Glassdoor reviews, is 4.4 out of 5, which translates to 88/100.

1
Reviews also indicate that salary is low compared to the industry.
2
No other specific data points for fair pay or worker respect metrics are available in the provided articles.

Fair Trade & Ethical Sourcing

-20

The company conducts internal processes and assessments for suppliers once every six months.

1
While supplier contracts include ethical sourcing clauses, the percentage of suppliers covered by these clauses is not specified, preventing a score for that KPI.
2

Honest & Fair Business

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business.

1
The articles primarily contained general company news, clinical trial updates, and financial reporting announcements, or were irrelevant to PDS Biotechnology Corporation.
2

Kind to Animals

0

No evidence available to assess PDS Biotechnology Corporation on Kind to Animals.

No War, No Weapons

0

No specific, concrete evidence was found in the provided articles regarding PDS Biotechnology Corporation's association with arms manufacturing, military contracts, or conflict facilitation. The articles either discuss general government procurement, defense technology trends, or are about a different company (Tonix Pharmaceuticals)

1
, and do not contain any data points relevant to PDSB.US for the 'No War, No Weapons' ethical value.

Planet-Friendly Business

-60

The company reported total Scope 1 and 2 emissions of 14,353 metric tonnes CO₂e.

1
While it accounts for 10 of 15 Scope 3 categories, the methodology for the remaining 5% is not detailed, indicating that Scope 3 is not fully published.
2
The company has committed to Science-Based Targets (SBTi) for emission reduction, but validation is pending.
3
It has a Net Zero target year of 2050.
4
The company generated 1.5 million kWh of renewable energy from solar in Bangladesh, mitigating over 10,000 tonnes of carbon emissions, but the percentage of total operational energy from renewables is not specified.
5
The company has achieved LEED Platinum certification through solar energy initiatives in Bangladesh and Sri Lanka, and LEED Gold certification, covering 20-30% of its major offices.
6
The company invested $50 million in sustainability start-ups, which represents 0.5-1% of its EBIT (calculated as $50M / $47M EBITDA, which is a proxy for EBIT).
7

Respect for Cultures & Communities

0

No evidence available to assess PDS Biotechnology Corporation on Respect for Cultures & Communities.

Safe & Smart Tech

0

No specific evidence was found in the provided articles regarding PDS Biotechnology Corporation's performance on any of the Safe & Smart Tech KPIs. While some articles discuss general cybersecurity trends and incidents within the pharmaceutical and biotech sectors, they do not provide concrete data points, actions, or policies directly attributable to PDSB.US concerning data protection, cybersecurity investment, AI ethics, privacy certifications, or other related metrics. The company's 10-K filing mentions general material weaknesses in internal control but does not link this to specific privacy or cybersecurity regulatory compliance.

1

Zero Waste & Sustainable Products

0

No evidence available to assess PDS Biotechnology Corporation on Zero Waste & Sustainable Products.

Own PDS Biotechnology Corporation?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.